Case 1: Acute Variceal Hemorrhage & Splanchnic Vasoconstrictor Therapy
A 54-year-old man with a history of alcohol use disorder is brought to the emergency department by his brother after two episodes of vomiting large amounts of bright red blood over the past 3 hours. He reports feeling progressively lightheaded, weak, and unable to walk without assistance. Over the past month, he has experienced worsening abdominal swelling, easy bruising, and progressive yellowing of his skin. He does not take any prescribed medications. Temperature is 36.8°C (98.2°F), blood pressure is 86/52 mm Hg, pulse is 118/min, and respirations are 20/min. Physical examination shows scleral icterus, multiple spider angiomas across the chest, a distended abdomen with shifting dullness, and caput medusae around the umbilicus. Laboratory studies reveal a hemoglobin of 7.6 g/dL, platelet count of 62,000/mm³, and an international normalized ratio (INR) of 1.9; intravenous crystalloid resuscitation and blood transfusion are promptly initiated. Which of the following pharmacologic agents is most appropriate to administer at this time?
AOctreotide— Correct Answer
Explanation: Intravenous octreotide is the initial pharmacotherapy of choice for acute variceal hemorrhage in patients with cirrhosis, working by inhibiting the release of splanchnic vasodilatory hormones to decrease portal venous inflow.
- The patient presents with massive upper gastrointestinal bleeding (hematemesis), hemodynamic instability (hypotension, tachycardia), and stigmata of decompensated cirrhosis with portal hypertension (scleral icterus, spider angiomas, ascites, caput medusae, thrombocytopenia, coagulopathy).
- In acute variceal hemorrhage, initial management consists of hemodynamic stabilization with volume resuscitation, restrictive blood transfusion (target hemoglobin 7–8 g/dL), prophylactic antibiotics (e.g., ceftriaxone), and pharmacotherapy to reduce portal pressures prior to emergent endoscopic variceal ligation.
- Octreotide is a long-acting synthetic somatostatin analog that inhibits the secretion of splanchnic vasodilatory peptides (primarily glucagon and vasoactive intestinal peptide). This results in selective splanchnic vasoconstriction, which decreases splanchnic blood flow, reduces portal venous inflow, and lowers variceal pressures to control active hemorrhage.
- Octreotide is administered as an intravenous bolus followed by a continuous infusion for 2 to 5 days in acute variceal bleeding.
- Adverse effects of octreotide include nausea, abdominal cramps, steatorrhea, and an increased risk of cholelithiasis due to inhibition of cholecystokinin (CCK) secretion and gallbladder hypomotility.
Case 2: Pulmonary Emphysema & Protease-Antiprotease Pathophysiology
A 64-year-old man comes to the clinic due to progressive shortness of breath on exertion and a chronic cough over the past 2 years. He reports that his dyspnea has gradually worsened, and he now has difficulty walking up a single flight of stairs. He has a 45-pack-year smoking history and no other chronic medical conditions. Physical examination shows a thin man in mild respiratory distress breathing through pursed lips, with an increased anteroposterior chest diameter. Breath sounds are decreased bilaterally with prolonged expiration and faint wheezing, and chest percussion reveals diffuse hyperresonance. Chest radiography demonstrates flattened diaphragms, increased retrosternal clear space, and hyperlucent lung fields bilaterally. Which of the following is the primary pathophysiologic mechanism of this patient's condition?
AProteolytic destruction of alveolar wall elastin— Correct Answer
BExcessive deposition of collagen by activated fibroblasts
CIgE-mediated degranulation of airway mast cells
DNoncaseating granulomatous inflammation of the interstitium
EImpaired clearance of secretions due to dynein arm defects
Explanation: Emphysema is an obstructive lung disease characterized by the proteolytic destruction of alveolar walls and elastin, primarily driven by cigarette smoke-induced inflammation and an imbalance between proteases (such as neutrophil elastase) and antiproteases (such as alpha-1 antitrypsin).
- Clinical presentation: The patient is a long-term smoker presenting with progressive exertional dyspnea, pursed-lip breathing, a barrel-shaped chest (increased anteroposterior diameter), hyperresonance to percussion, prolonged expiration, and chest radiography showing flattened diaphragms with hyperlucent lung fields. These findings represent a prototypical presentation of emphysema, a major subtype of chronic obstructive pulmonary disease (COPD).
- Cellular pathophysiology: Inhaled cigarette smoke irritates the respiratory epithelium, stimulating alveolar macrophages to release chemoattractants (such as CXCL8/IL-8 and leukotriene B4) that recruit neutrophils to the lung parenchyma. Activated neutrophils and macrophages secrete excess proteases, predominantly neutrophil elastase and matrix metalloproteinases.
- Pathologic consequence: These proteases overwhelm endogenous antiproteases (such as alpha-1 antitrypsin), leading to degradation of elastin and extracellular matrix components of the alveolar septa. The destruction of alveolar walls results in permanent enlargement of airspaces distal to terminal bronchioles, loss of pulmonary elastic recoil, dynamic airway collapse during expiration, and air trapping.
- Centriacinar emphysema is the most common form of emphysema, characteristically affecting the upper lobes of long-term cigarette smokers due to a protease-antiprotease imbalance.
- Loss of alveolar elastin reduces radial traction on small airways and decreases elastic recoil, causing increased lung compliance, air trapping, and a reduced FEV1/FVC ratio.
Case 3: Chronic Lymphocytic Leukemia & Active Surveillance Strategy
A 68-year-old man presents to the clinic for a routine annual health examination. He reports feeling well, with no fevers, night sweats, fatigue, or unintentional weight loss. His past medical history is notable only for well-controlled primary hypertension. Temperature is 37.0 C (98.6 F), blood pressure is 128/78 mm Hg, pulse is 72/min, and respirations are 14/min. Physical examination reveals no palpable cervical, axillary, or inguinal lymphadenopathy, and the abdomen is soft with no hepatosplenomegaly. Laboratory evaluation shows a hemoglobin of 14.5 g/dL, platelet count of 210,000/mm3, and leukocyte count of 42,000/mm3 with 86% mature lymphocytes. Peripheral blood smear demonstrates numerous fragile, disrupted lymphocytes (smudge cells), and flow cytometry confirms a clonal B-cell population co-expressing CD5, CD19, and CD23. Which of the following is the most appropriate next step in management?
AActive surveillance— Correct Answer
BBruton tyrosine kinase inhibitor therapy
CCombination chemoimmunotherapy
DSystemic glucocorticoid therapy
EAllogeneic hematopoietic stem cell transplantation
Explanation: Asymptomatic, early-stage chronic lymphocytic leukemia (Rai stage 0) does not benefit from immediate systemic therapy; the established standard of care is active surveillance with regular clinical and laboratory monitoring.
- Clinical recognition: The patient is an asymptomatic elderly male with marked absolute lymphocytosis, smudge cells on peripheral smear, and flow cytometry demonstrating mature B cells co-expressing CD5, CD19, and CD23. This is classic for chronic lymphocytic leukemia (CLL).
- Staging assessment: The absence of lymphadenopathy, hepatomegaly, splenomegaly, anemia, and thrombocytopenia categorizes this presentation as Rai stage 0 (low-risk disease).
- Management decision: Multiple randomized clinical trials have established that initiating pharmacotherapy in early, asymptomatic CLL does not confer an overall survival benefit and exposes patients to unnecessary toxicity. Therefore, watchful waiting (active surveillance) with periodic physical examinations and complete blood counts is the standard of care.
- Chronic lymphocytic leukemia (CLL) is a malignancy of mature B cells characterized by CD5, CD19, CD20, and CD23 expression and smudge cells on peripheral smear.
- Rai stage 0 CLL (isolated lymphocytosis without cytopenias or organ involvement) is managed with active surveillance rather than immediate pharmacotherapy.
Case 4: Idiopathic Pulmonary Fibrosis & High-Resolution Chest CT
A 66-year-old man presents to the clinic with an 8-month history of progressively worsening shortness of breath on exertion and a persistent, nonproductive cough. He reports that he previously walked 2 miles daily without difficulty but is now breathless after climbing a single flight of stairs. He has no history of tobacco use, occupational exposures, or systemic symptoms such as fever, night sweats, or weight loss. Vital signs are temperature 37.0°C (98.6°F), blood pressure 128/78 mm Hg, pulse 76/min, and respirations 20/min; pulse oximetry shows an oxygen saturation of 94% at rest on ambient air, dropping to 88% after a 6-minute walk test. Physical examination reveals digital clubbing and bilateral, dry, fine end-inspiratory crackles heard predominantly at the lung bases, with no jugular venous distension or peripheral edema. High-resolution CT of the chest demonstrates patchy subpleural reticular opacities, traction bronchiectasis, and honeycombing localized predominantly to the peripheral lower lung zones. Which of the following is the primary pathophysiologic mechanism underlying this patient's condition?
AExcessive deposition of extracellular matrix collagen— Correct Answer
BEnzymatic degradation of alveolar extracellular elastin
CHypertrophy and hyperplasia of submucosal bronchial glands
DPermanent airway dilation due to chronic necrotizing infection
ENoncaseating granulomatous inflammation driven by helper T cells
Explanation: Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease characterized clinically by exertional dyspnea, dry cough, digital clubbing, and bilateral bibasilar end-inspiratory crackles, driven pathophysiologically by repetitive alveolar epithelial microinjury and excessive extracellular matrix collagen deposition.
- Clinical presentation: The patient is an older male presenting with insidious, progressive exertional dyspnea, dry cough, digital clubbing, and bibasilar fine end-inspiratory ("Velcro-like") crackles. High-resolution CT shows peripheral, subpleural reticular opacities, traction bronchiectasis, and honeycombing concentrated at the lung bases, which is the classic usual interstitial pneumonia (UIP) pattern diagnostic of idiopathic pulmonary fibrosis (IPF).
- Pathophysiologic mechanism: IPF is triggered by repetitive microinjury to alveolar type I pneumocytes in genetically susceptible individuals, followed by aberrant wound repair. Injured alveolar epithelial cells fail to regenerate appropriately and instead secrete profibrotic cytokines, primarily transforming growth factor-beta (TGF-β) and platelet-derived growth factor (PDGF).
- Linking mechanism to option: These signaling pathways trigger uninhibited fibroblast and myofibroblast proliferation, resulting in excessive deposition of extracellular matrix proteins (predominantly collagen) into the pulmonary interstitium. This progressive fibrosis decreases pulmonary compliance and impairs gas exchange.
- Idiopathic pulmonary fibrosis is characterized by repetitive alveolar epithelial injury leading to uncontrolled TGF-β release and excessive extracellular matrix collagen deposition.
- The hallmark imaging finding on high-resolution CT is a usual interstitial pneumonia (UIP) pattern: subpleural, basilar-predominant reticulation, traction bronchiectasis, and honeycombing.
Case 5: Zollinger-Ellison Syndrome & Gastrinoma Pathophysiology
A 44-year-old man presents to the outpatient clinic with a 5-month history of persistent, burning epigastric pain and worsening diarrhea. The pain occasionally awakens him at night and is only minimally relieved by food or double-dose omeprazole. He reports passing four to five voluminous, foul-smelling, loose stools daily that are difficult to flush, which has forced him to reduce his working hours. His medical history is significant for two hospitalizations over the past 2 years for bleeding duodenal ulcers treated with endoscopic clipping. Temperature is 37.1°C (98.8°F), pulse is 78/min, blood pressure is 126/78 mm Hg, and respirations are 14/min. Abdominal examination reveals mild tenderness in the epigastrium without guarding, rigidity, or hepatosplenomegaly. Upper endoscopy demonstrates prominent, thickened gastric folds along with multiple ulcerations in the descending duodenum and proximal jejunum; fasting serum gastrin is 680 pg/mL (reference: < 100 pg/mL), and intravenous secretin administration results in an increase to 1,120 pg/mL. Which of the following is the most likely mechanism responsible for this patient's diarrhea?
AOsmotic fluid shifts from unabsorbed luminal carbohydrates
BInactivation of pancreatic digestive enzymes— Correct Answer
CImpaired terminal ileal bile acid reabsorption
DIncreased enterocyte cyclic adenosine monophosphate
EAutoimmune destruction of intestinal villous architecture
Explanation: Zollinger-Ellison syndrome (gastrinoma) causes severe peptic ulcer disease and steatorrhea primarily because massive gastric acid hypersecretion overwhelms duodenal buffering capacity, lowering luminal pH and irreversibly inactivating pancreatic digestive enzymes.
- Clinical recognition: The patient presents with recurrent peptic ulcer disease refractory to proton pump inhibitors, post-bulbar and jejunal ulcerations, hypertrophic gastric rugal folds (driven by the trophic effects of gastrin on parietal cells), and chronic diarrhea with steatorrhea (foul-smelling, difficult-to-flush stools). A paradoxical rise in serum gastrin following intravenous secretin administration confirms Zollinger-Ellison syndrome (gastrinoma).
- Underlying pathophysiology: Under normal conditions, acidic gastric contents are neutralized in the duodenum by pancreatic bicarbonate secretion, maintaining an intraluminal pH of 6.0 to 7.0 that is optimal for digestion. In gastrinoma, autonomous gastrin secretion produces massive hydrochloric acid hypersecretion that saturates pancreatic bicarbonate buffering.
- Confirmatory deduction: An excessively acidic duodenal environment (pH < 5.5) irreversibly denatures and inactivates acid-labile pancreatic digestive enzymes, specifically pancreatic lipase. Concurrently, low pH precipitates conjugated bile salts, disrupting micelle formation. Unhydrolyzed lipids remain unabsorbed in the intestinal lumen, causing fat malabsorption, steatorrhea, and osmotic secretory diarrhea.
- Zollinger-Ellison syndrome is caused by a gastrin-secreting neuroendocrine tumor (gastrinoma), commonly located within the gastrinoma triangle (duodenum and pancreas), and may be sporadic or part of MEN1.
- The secretin stimulation test is confirmatory: secretin inhibits physiological antral G cells but paradoxically stimulates gastrin release from gastrinoma cells.
- Diarrhea and steatorrhea in gastrinoma occur due to acid-mediated inactivation of pancreatic lipase, bile acid precipitation, and high-volume fluid secretion.
